LFST (LifeStance Health Group) EPS without NRI: $0.06 (TTM As of Mar. 2026)


LFST LifeStance Health Group Inc LFST
57 GF Score
Price $9.65
GF Value $8.22
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is LifeStance Health Group EPS without NRI?

LifeStance Health Group LFST +2.22% 57 EPS without NRI is $0.06 as of Mar. 2026. GuruFocus rates LFST with a GF Score™ of 57/100 and a GF Value™ of $8.22 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 512 Healthcare Providers & Services companies, LifeStance Health Group ranks worse than 195312.3% on this metric.

LifeStance Health Group's earnings per share without non-recurring items for the three months ended in Mar. 2026 was $0.04. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $0.06.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for LifeStance Health Group's EPS without NRI or its related term are showing as below:

During the past 7 years, LifeStance Health Group's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 47.20% per year. The lowest was 47.20% per year. And the median was 47.20% per year.

LFST's 3-Year EPS without NRI Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 11
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

LifeStance Health Group's EPS (Diluted) for the three months ended in Mar. 2026 was $0.04. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.06.

LifeStance Health Group's EPS (Basic) for the three months ended in Mar. 2026 was $0.04. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.07.


LifeStance Health Group  (NAS:LFST) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


LifeStance Health Group EPS without NRI Related Terms


LifeStance Health Group EPS without NRI Historical Data

* Premium members only.

The historical data trend for LifeStance Health Group's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LifeStance Health Group EPS without NRI Chart

LifeStance Health Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial -1.03 -0.60 -0.52 -0.15 0.02

LifeStance Health Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.01 0.00 0.03 0.04

LFST vs NHC, BKD, CON: EPS without NRI Comparison

For the Medical Care Facilities subindustry, LifeStance Health Group's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LifeStance Health Group PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where LifeStance Health Group's PE Ratio without NRI falls into.


LFST
57GF Score
LifeStance Health Group Inc LFST
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LifeStance Health Group EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $0.06 mean?
LifeStance Health Group (LFST) has a EPS without NRI of $0.06 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on LifeStance Health Group and its competitors. According to the industry distribution chart, LifeStance Health Group ranks #999999 out of 512 companies in the Healthcare Providers & Services industry.
Is LifeStance Health Group's EPS without NRI too high?
LifeStance Health Group's current EPS without NRI is $0.06. The Healthcare Providers & Services industry median EPS without NRI is 11.00. LifeStance Health Group's value of $0.06 is 99.5% below this industry median. Based on the distribution chart, LifeStance Health Group ranks #999999 out of 512 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, LifeStance Health Group has a GF Score™ of 57/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's EPS without NRI compare to NHC and BKD?
According to the Healthcare Providers & Services industry distribution chart, LifeStance Health Group ranks #999999 out of 512 companies for EPS without NRI. This places LifeStance Health Group in the lower half of its industry. The industry median EPS without NRI is 11.00. LifeStance Health Group's value of $0.06 is 99.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.00, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeStance Health Group's current EPS without NRI of $0.06 is 99.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on LifeStance Health Group and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeStance Health Group's current EPS without NRI is $0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.22, compared to a current price of $9.65 — trading 17.4% above its estimated fair value. The current EPS without NRI is $0.06 and 99.5% below the Healthcare Providers & Services industry median of 11.00. LifeStance Health Group's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current EPS without NRI is $0.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LifeStance Health Group (LFST) Overvalued in 2026?

Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued. The current stock price of $9.65 is trading 17.4% above its estimated GF Value™ of $8.22. GuruFocus considers LifeStance Health Group to be Modestly Overvalued.

Key valuation signals for LFST:

  • EPS without NRI: $0.06
  • GF Value™: $8.22 vs. price of $9.65 (17.4% above fair value)
  • GF Score™: 57/100 with 5 warning signs
  • Industry Position: 99.5% below the Healthcare Providers & Services median (#999999 of 512)

No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


LifeStance Health Group Business Description

Address 4800 North Scottsdale Road, Suite 2500, Scottsdale, AZ, USA, 85251
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
57GF Score

Get the complete analysis for LFST

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.65
Price
$8.22
GF Value